On the other hand, CPVT patients exhibit arrhythmias only during acute and intense adrenergic stimulation when PKA, besides phosphorylating RyR2, activates SERCA2a, which increases SR Ca2+ uptake and SR Ca2+ load. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.